Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for m 2), P
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Most Relevant Literature
- Exciplexes with ionic dopants: stability, structure, and experimental relevance of M(+)((2)P)(4)He(n…
- Use of the cardiac power index to predict fluid responsiveness in the prone position: a proof-of-con…
- High Lymphocyte Count as a Significant Risk Factor for Incisional Hernia After Laparoscopic Colorect…
- Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation…
- Estimation of renal function using iodine maps in dual-energy spectral computed tomography urography…
Most Relevant Clinical Trials
- Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg
- Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra
- Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine
- Retrospective Study in a NSCLC M+ p
- P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine
